RNU7-35P: A Promising Drug Target / Biomarker (G100147822)

Target Name: RNU7-35P

NCBI ID: G100147822

Other Name(s): U7.35 | RNA, U7 small nuclear 35 pseudogene

RNU7-35P: A Promising Drug Target / Biomarker

The identifier RNAU7-35P is a non-coding RNA molecule that has been identified as a potential drug target or biomarker. RNAU7-35P is a small non-coding RNA molecule that is found in various tissues and cells in the human body. It is characterized by its unique structure, which consists of a single exon that is usually expressed at low levels.

The discovery of RNAU7-35P

RNAU7-35P was first identified using RNA sequencing techniques. Researchers found that RNAU7-35P is a single-exon RNA molecule that is expressed in various tissues and cells in the human body. The molecule is characterized by its unique structure, which consists of a single exon that is usually expressed at low levels.

The potential drug target or biomarker properties of RNAU7-35P

RNAU7-35P has been shown to have various potential drug target or biomarker properties. One of the most promising potential drug targets for RNAU7-35P is its role in cancer. Studies have shown that high levels of RNAU7-35P are associated with poor prognosis in various types of cancer, including breast, ovarian, and colorectal cancers.

RNAU7-35P has also been shown to play a role in inflammation. Studies have shown that RNAU7-35P is involved in the regulation of inflammation-related genes, including those that are involved in the production of pro-inflammatory cytokines. This suggests that RNAU7-35P may be a potential therapeutic target for treating inflammatory diseases.

The potential utility of RNAU7-35P as a drug target or biomarker

The potential utility of RNAU7-35P as a drug target or biomarker is due to its unique structure and various biochemical properties. The single-exon structure of RNAU7-35P allows it to have unique interactions with other molecules, which may be involved in its function. Additionally, RNAU7-35P has been shown to have various functions in various cellular processes, including cell growth, apoptosis, and inflammation.

RNAU7-35P may also be a potential biomarker for various diseases, including cancer and inflammatory diseases. Studies have shown that high levels of RNAU7-35P are associated with poor prognosis in various types of cancer, including breast, ovarian, and colorectal cancers. Additionally, RNAU7-35P has been shown to be involved in the regulation of inflammation-related genes, which suggests that it may be a potential therapeutic target for treating inflammatory diseases.

Conclusion

RNAU7-35P is a small non-coding RNA molecule that has been identified as a potential drug target or biomarker. Its unique structure and various biochemical properties make it a promising candidate for further study. Further research is needed to determine the full potential of RNAU7-35P as a drug target or biomarker.

Protein Name: RNA, U7 Small Nuclear 35 Pseudogene

More Common Targets